Peninsula Health Service, Frankston, Victoria, Australia Monash University, Frankston, Victoria, Australia.
Monash University, Frankston, Victoria, Australia Department of Monash Health, Cheltenham, Victoria, Australia.
Br J Sports Med. 2016 Oct;50(20):1268-1275. doi: 10.1136/bjsports-2015-094986. Epub 2016 Feb 25.
Calcaneal apophysitis, is a relatively common cause of heel pain in children. Very few randomised studies have evaluated treatment options. This trial compared the effectiveness of currently employed treatment options for the relief of pain and disability associated with calcaneal apophysitis.
Factorial 2×2 randomised comparative effectiveness trial with 1, 2, 6 and 12-month follow-up.
Participants were recruited from the caseload of podiatrists at Monash health and Peninsula Health.
Children aged 8-14 years with clinically diagnosed calcaneal apophysitis.
Treatment factor 1: two different types of in-shoe orthoses: a heel raise or prefabricated orthoses. Treatment factor 2: footwear replacement or no footwear replacement.
Our primary outcome was functional disability, the secondary outcomes were pain and ankle dorsiflexion range.
A total of 133 children and their parents responded to the recruitment advertisement, 124 participated in the trial.At the 1 and 2-month follow-up points, there was a main effect of the shoe insert (heel raise) in only the physical domain for the Oxford ankle foot questionnaire (p=0.04). At the 6 and 12-month follow-up points, there was no main effect or interaction effect for any outcome measure.
This trial indicates at the 2-month time point there is a relative advantage in the use of heel raises over prefabricated orthoses for the treatment for calcaneal apophysitis. At 12 months there was no relative advantage to any one of the investigated treatment choices over another. Therefore, if a physical impact is experienced for greater than 2 months, the selection of treatment choice may defer to clinical judgement, cost-minimisation and or patient preference.
ACTRN12609000696291.
跟骨骨突炎是儿童足跟痛的一个相对常见的原因。很少有随机研究评估过治疗方案。本试验比较了目前用于缓解跟骨骨突炎相关疼痛和残疾的治疗选择的有效性。
具有 1、2、6 和 12 个月随访的因子 2×2 随机对照有效性试验。
参与者是从莫纳什卫生和半岛卫生的足病医生的病例中招募的。
年龄在 8-14 岁之间、临床诊断为跟骨骨突炎的儿童。
治疗因素 1:两种不同类型的内置矫形器:脚跟抬高或预制矫形器。治疗因素 2:更换鞋类或不更换鞋类。
共有 133 名儿童及其父母对招募广告做出了回应,其中 124 名参与了试验。在 1 个月和 2 个月的随访点,牛津踝关节足问卷的物理领域仅存在鞋插入物(脚跟抬高)的主要影响(p=0.04)。在 6 个月和 12 个月的随访点,对于任何结果测量都没有主要影响或交互作用。
本试验表明,在治疗跟骨骨突炎方面,在 2 个月的时间点,使用脚跟抬高相对于预制矫形器有相对优势。在 12 个月时,任何一种治疗选择都没有相对优势。因此,如果物理影响持续超过 2 个月,治疗选择的选择可能会推迟到临床判断、成本最小化和/或患者偏好。
ACTRN12609000696291。